Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Turoctocog alfa pegol in Haemophilia A Surgery
NCT01489111Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2012
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 21
01
Overview
A Phase 3 trial of turoctocog alfa pegol in hemophilia A, sponsored by Novo Nordisk. Started Aug 2012; status: completed.
02
Drugs
turoctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01489111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01489111.